Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

CNN exposes an online network of men encouraging each other to drug and assault their partners, and swap tips on how to get ...